The outlook of companies tied to flagship drugs like Viagra presents a nuanced investment landscape . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the loss of exclusivity in key territories has introduced considerable volatility. Investors are now assessing the impact of rival medi